Keyphrases
Hormone Therapy
100%
Tau Positron Emission Tomography
100%
Sex-related Differences
100%
Amyloid Burden
33%
Cognitively Normal
33%
Amyloid Positron Emission Tomography
33%
Cognitive Performance
22%
Sex Hormones
22%
Tau Pathology
11%
Amyloid Pathology
11%
Alzheimer's Disease
11%
Clinical Trials
11%
Rostral
11%
Neuroimaging Studies
11%
Neuropsychological Tests
11%
Late-onset Alzheimer's Disease
11%
Deleterious Effects
11%
Multiple Regions
11%
Sex Effect
11%
Older Individuals
11%
Alzheimer's Disease Pathology
11%
Disease Prevalence
11%
Alzheimer Disease Research Center
11%
Knight
11%
Clinical Practice
11%
Female Sex
11%
Sporadic Alzheimer's Disease
11%
Negatively Associated
11%
Major Risk Factors
11%
Neurodegenerative
11%
Temporal Region
11%
Therapy Effect
11%
Protective Factors
11%
Middle Temporal
11%
Cross-sectional Cohort
11%
Superior Temporal
11%
Brain Integrity
11%
Female Participants
11%
Tau Burden
11%
Medication History
11%
Cognition Testing
11%
Sex Therapy
11%
Medicine and Dentistry
Positron Emission Tomography
100%
Tau
100%
Hormone Therapy
100%
Amyloid Protein
75%
Alzheimer's Disease
33%
Sex Hormone
16%
Prevalence
8%
Therapy Effect
8%
Neuropsychological Testing
8%
Protective Factor
8%
Sex Therapy
8%
Neuroscience
Positron Emission Tomography
100%
Hormone Therapy
100%
Amyloid Protein
81%
Alzheimer's Disease
36%
Sex Hormone
18%
Longitudinal Study
9%